da-kuk
- Canada's NervGen Pharma (OTCQX:NGENF) said it granted 400K incentive stock options to its directors.
- The stock options are exercisable at a price of C$1.74 per share for five years.
- The company noted all options were granted in accordance with the policies of the TSX Venture Exchange and the company's stock option plan.